- Home
- VRA vs ABOS Comparison
VRA vs ABOS Comparison
Compare VRA & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- ABOS
- Stock Information
- Founded
- VRA 1982
- ABOS 1996
- Country
- VRA United States
- ABOS United States
- Employees
- VRA N/A
- ABOS N/A
- Industry
- VRA Apparel
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- ABOS Health Care
- Exchange
- VRA Nasdaq
- ABOS Nasdaq
- Market Cap
- VRA 102.9M
- ABOS 99.1M
- IPO Year
- VRA 2010
- ABOS 2021
- Fundamental
- Price
- VRA $3.72
- ABOS $1.56
- Analyst Decision
- VRA Strong Buy
- ABOS Strong Buy
- Analyst Count
- VRA 1
- ABOS 3
- Target Price
- VRA $5.50
- ABOS $9.33
- AVG Volume (30 Days)
- VRA 363.1K
- ABOS 379.4K
- Earning Date
- VRA 12-11-2024
- ABOS 11-12-2024
- Dividend Yield
- VRA N/A
- ABOS N/A
- EPS Growth
- VRA N/A
- ABOS N/A
- EPS
- VRA N/A
- ABOS N/A
- Revenue
- VRA $405,268,000.00
- ABOS N/A
- Revenue This Year
- VRA N/A
- ABOS N/A
- Revenue Next Year
- VRA $4.90
- ABOS N/A
- P/E Ratio
- VRA N/A
- ABOS N/A
- Revenue Growth
- VRA N/A
- ABOS N/A
- 52 Week Low
- VRA $3.27
- ABOS $1.54
- 52 Week High
- VRA $8.32
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- VRA 40.52
- ABOS 30.29
- Support Level
- VRA $3.46
- ABOS $1.69
- Resistance Level
- VRA $3.97
- ABOS $1.88
- Average True Range (ATR)
- VRA 0.22
- ABOS 0.13
- MACD
- VRA 0.05
- ABOS -0.00
- Stochastic Oscillator
- VRA 54.88
- ABOS 4.88
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.